Fosmidomycin

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameFosmidomycin
Drug Alias Namefosmidomicina膦胺霉素fosmidomycinefosmidomycinumFR-31564
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxidoreductases inhibitorsProtein biosynthesis inhibitors
TargetsOxidoreductases
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryThailandGabon
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma IncItalfarmaco
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksWikipedia